Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of hemostatic powder and traditional Chinese medicine, which is applied in the field of human medicine, can solve the problems of heavy burden on patients and high cost of clinical use, and achieve the effects of promoting wound healing, good hemostasis, and reducing wound exudation
Inactive Publication Date: 2009-09-23
徐樊
View PDF0 Cites 15 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0008] The disadvantage of the above-mentioned hemostatic drugs is that the cost of clinical use is relatively high, resulting in a heavy burden on patients
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0022] Example 1: The composition of the drug is (weight unit: gram, the same below), 1.5 Panax notoginseng, 9 stamens, 3 frankincense, 9 myrrh, 1 blood, 10 safflower, 10 red stone fat, and 9 hematoxylin. The components used are washed and dried, crushed and mixed.
Embodiment 2
[0023] Example 2: Panax notoginseng 3, stamen 3, frankincense 9, myrrh 3, dried blood 1.5, safflower 3, red stone fat 18, hematoxylin 3.
Embodiment 3
[0024] Example 3: Panax notoginseng 2, stamen 5, frankincense 5, myrrh 5, dried blood 1.2, safflower 5, red stone fat 14, hematoxylin 5.
[0025] The above-mentioned embodiment medicine is used for anal fistula, anal fissure, mixed hemorrhoids and other anal diseases postoperative wound hemostasis and local dressing change. After 200 cases of clinical observation □ the effect is satisfactory, the report is as follows.
[0026] 1. Clinical data:
[0027] The group consisted of 112 males and 88 females; aged 18 to 60 years. Among them, there were 72 cases of anal fistula, 68 cases of mixed hemorrhoid, 25 cases of external hemorrhoid, and 35 cases of anal fissure.
[0028] 2. Drug composition and production method: hemostatic powder is crushed and sieved by Panax notoginseng 2, stamen 5, frankincense 5, myrrh 5, dried blood 1.2, safflower 5, red stone fat 14, hematoxylin 5 (weight unit is gram) (120 mesh), stir and mix, and use in 10g per bag. When the operation of anal fistu...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention aims at providing a Chinese medicine hemostatic powder which is used for externally stanching and lowering the treatment cost of the prior hemostatic medicine. The Chinese medicine hemostatic powder is prepared by the following Chinese medicines according to the weight account: 1.5-3 portions of panax pseudo-ginseng var. notoginseng, 3-9 portions of marmor serpentinatum, 3-9 portions of frankincense, 3-9 portions of myrrh, 1-1.5 portions of dragon's blood, 3-10 portions of safflower, 10-18 portions of halloysitum rubrum and 3-9 portions of sapanwood. The hemostatic powder is the Chinese medicine for external use, which is prepared by combining the characteristics of wound external hemorrhage according to the medicine function effect, has good hemostatic action after the operation, and has remarkable effects of reducing the wound surface effusion, resisting infection and promoting the wound healing. Compared with the prior hemostatic medicine, the invention has equal hemostatic effect, but the cost is 20 percent of average price of the prior hemostatic medicine.
Description
technical field [0001] The invention belongs to the technical field of medicines for human use, in particular to traditional Chinese medicine preparations for external hemostasis. Background technique [0002] Surgical operations or trauma, especially bleeding and oozing, are sometimes difficult to control, which will not only increase blood loss but also increase the difficulty of surgery, and even endanger life. Cao Jinduo, a surgical expert at the Beijing Hospital of the Ministry of Health, believes that any surgical operation involves bleeding and hemostasis almost without exception, and good hemostasis is the prerequisite and guarantee for safe operation. Reasonable selection of hemostasis methods during surgery can control wound bleeding and oozing, ensure a clear surgical field, improve surgical efficiency, shorten surgical time, thereby reducing blood loss and blood transfusion, which is conducive to avoiding the occurrence of intraoperative and postoperative complic...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more